CEO: Dan Bradbury

No. of employees: 11

Headquarters: La Jolla

Year Founded: 2017

Stock symbol and exchange: EQ on Nasdaq

Fundraising: In October raised $71.6 million in an initial public offering

Company description: Equillium is developing drugs for potential immuno-inflammatory diseases, including a tissue transplant disease.

Equillium went from founding to a Nasdaq listing in only 16 months, indicating a biotech moving at warp speed...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $129